0001104659-23-011714.txt : 20230207 0001104659-23-011714.hdr.sgml : 20230207 20230207160019 ACCESSION NUMBER: 0001104659-23-011714 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220701 FILED AS OF DATE: 20230207 DATE AS OF CHANGE: 20230207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Butler Erin CENTRAL INDEX KEY: 0001940413 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37544 FILM NUMBER: 23594986 MAIL ADDRESS: STREET 1: 4375 LOMA RIVIERA COURT CITY: SAN DIEGO STATE: CA ZIP: 92110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Armata Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4503 GLENCOE AVENUE CITY: MARINA DEL REY STATE: CA ZIP: 90292 BUSINESS PHONE: 310-665-2928 MAIL ADDRESS: STREET 1: 4503 GLENCOE AVENUE CITY: MARINA DEL REY STATE: CA ZIP: 90292 FORMER COMPANY: FORMER CONFORMED NAME: AmpliPhi Biosciences Corp DATE OF NAME CHANGE: 20130222 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 3 1 tm235775-1_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2022-07-01 0 0000921114 Armata Pharmaceuticals, Inc. ARMP 0001940413 Butler Erin 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 0 1 0 0 Vice President,Finance & Admin Stock Option (Right to Buy) 14.28 2027-09-17 Common Stock 714 D Stock Option (Right to Buy) 3.15 2029-05-22 Common Stock 15000 D Stock Option (Right to Buy) 5.14 2031-03-24 Common Stock 30000 D Stock Option (Right to Buy) 5.11 2032-04-12 Common Stock 50000 D Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Issuer's 2016 Equity Incentive Plan (the "2016 EIP"). All 714 stock options are fully vested and exercisable. Reflects the grant of stock options to purchase shares of common stock of the Issuer under the 2016 EIP. 11,250 of the stock options are fully vested and exercisable. 3,750 of the stock options will vest on May 22, 2023. Reflects the grant of stock options to purchase shares of common stock of the Issuer under the 2016 EIP. 7,500 of the stock options are fully vested and exercisable. 7,500 of the stock options will vest on March 25, 2023, 7,500 of the stock options will vest on March 25, 2024, and 7,500 of the stock options will vest on March 25, 2025. Reflects the grant of stock options to purchase shares of common stock of the Issuer under the 2016 EIP. None of the stock options have fully vested and become exercisable. 12,500 of the stock options will vest on April 13, 2023, 12,500 of the stock options will vest on April 13, 2024, 12,500 of the stock options will vest on April 13, 2025, and 12,500 of the stock options will vest on April 13, 2026. /s/ Erin Butler 2023-02-07